Loading: 100%
CHEMED CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 14,613 (as per Q4 2015)no data available
Sector Health Care Providers, HealthcareHealth Care Providers, Healthcareno data available
Ticker CHEno data available
Financial year endsFY ends End of no data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17125150175200225
datesClosing price (adj.)
13.10.2017199.69
11.10.2017203.10
04.10.2017204.17
27.09.2017197.10
20.09.2017190.48
13.09.2017192.64
06.09.2017196.66
30.08.2017192.20
23.08.2017190.61
16.08.2017191.17
09.08.2017195.07
02.08.2017194.88
26.07.2017202.16
19.07.2017201.75
12.07.2017202.97
05.07.2017205.67
27.06.2017202.47
20.06.2017203.55
13.06.2017208.22
06.06.2017206.80
30.05.2017201.84
23.05.2017201.34
16.05.2017201.71
09.05.2017202.60
02.05.2017205.31
25.04.2017185.78
18.04.2017181.55
11.04.2017185.90
04.04.2017182.73
28.03.2017186.28
21.03.2017185.14
14.03.2017183.01
07.03.2017179.79
28.02.2017178.06
21.02.2017175.61
14.02.2017169.82
07.02.2017165.52
31.01.2017165.39
24.01.2017166.46
17.01.2017165.39
10.01.2017162.75
03.01.2017161.43
27.12.2016159.96
19.12.2016158.86
12.12.2016153.64
05.12.2016151.43
28.11.2016147.98
21.11.2016146.88
14.11.2016147.52
07.11.2016136.86
31.10.2016140.56
24.10.2016138.84
17.10.2016140.47
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
199.69n/a
Market Capitalisation
in million USD
3,233n/a
Enterprise Value
in million USD
3,363n/a
Common Shares Outstanding
as per Jun 30, 2016
16,190,702n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
16,713,000n/a
Average Diluted Shares Outstanding
TTM
17,200,250n/a
Index Membership
n/a
Business Summary
Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services.
no data available
Key Financials & Ratios (all figures TTM as per Nov 30, -1, million USD, full statements further below)
Profit & Loss
Revenues 1,566n/a
Gross Profit 463n/a
Operating Income 182n/a
EBITDA 0n/a
Net Profit 108n/a
Balance Sheet
Cash and Cash Equivalents 17n/a
Receivables 99n/a
Total Current Assets 147n/a
PP&E 119n/a
Total Assets 853n/a
Accounts Payable 42n/a
Current Debt 8n/a
Total Current Liabilities 167n/a
Long-Term Debt 140n/a
Total Liabilities 394n/a
Total Equity 459n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 29.6%n/a
Operating Margin 11.6%n/a
Net Profit Margin 6.9%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS 6.49n/a
Diluted EPS 6.31n/a
Sales per Share 93.68n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 30.76n/a
Price to Sales Ratio 2.13n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.14n/a
Other Ratios
Current Ratio 87.8%n/a
Liabilities to Equity Ratio 85.8%n/a
Debt to Assets Ratio 17.3%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
1,149
1,190
1,281
1,356
1,430
1,413
1,456
1,543
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-811
-835
-906
-970
-1,033
-1,009
-1,035
-1,088
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
338
356
375
385
397
405
422
456
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-206
-229
-231
-232
-240
-271
-253
-271
Selling, General & Administrative
-175
-197
-202
-202
-209
-216
-223
-238
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
Depreciation & Amortization
-28
-28
-29
-29
-31
-29
-31
-33
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
-3
-4
0
0
-1
-26
0
0
Operating Income (Loss)
133
126
144
154
156
133
168
184
Non-Operating Income (Loss)
-21
-6
-10
-13
-11
-10
-6
-4
Interest Expense, net
-12
-12
-12
-14
-15
-15
-8
-4
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-9
6
2
1
4
5
3
-1
Pretax Income (Loss), Adjusted
112
121
134
141
146
124
163
180
Abnormal Gains (Losses)
3
0
0
0
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
115
121
134
141
146
124
163
180
Income Tax (Expense) Benefit, net
-47
-47
-52
-55
-57
-47
-63
-70
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
68
74
82
86
89
77
99
110
Net Extraordinary Gains (Losses)
-1
0
0
0
0
0
0
0
Discontinued Operations
-1
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
67
74
82
86
89
77
99
110
Minority Interest
0
0
0
0
0
0
0
0
Net Income
67
74
82
86
89
77
99
110
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
67
74
82
86
89
77
99
110
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
112
50
38
70
84
14
15
Cash & Cash Equivalents
n/a
112
50
38
70
84
14
15
Short Term Investments
n/a
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
53
113
78
93
92
125
106
Accounts Receivable, Net
n/a
53
113
78
93
92
125
106
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
8
8
9
7
7
6
6
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
25
26
26
28
42
30
24
Prepaid Expenses
n/a
10
10
11
11
18
11
13
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
14
15
13
14
20
15
0
Income Taxes Receivable
n/a
1
1
2
3
4
3
11
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
198
197
151
198
225
175
151
Property, Plant & Equipment, Net
n/a
75
79
83
92
93
105
117
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
546
554
562
570
576
580
584
Intangible Assets
n/a
58
58
58
57
57
56
55
Goodwill
n/a
450
458
461
466
467
467
472
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
38
38
43
47
53
57
57
Total Noncurrent Assets
n/a
621
633
645
662
669
685
702
Total Assets
n/a
819
830
796
860
894
860
852
Liabilities and owners' equity
Payables & Accruals
n/a
122 121957000
133 133201000
127 126549000
141 140682000
155 155261000
145 144952000
142 141717000
Accounts Payable
n/a
52 52071000
56 55829000
48 48225000
48 48472000
42 41758000
47 46849000
44 43695000
Accrued Taxes
n/a
0 63000
1 1161000
0 90000
5 4938000
0 111000
6 5818000
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
70 69823000
76 76211000
78 78234000
87 87272000
113 113392000
92 92285000
98 98022000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
184 183564000
6 6250000
8 7500000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
14 14127000
16 16141000
19 18851000
16 16140000
25 25161000
24 24352000
22 22119000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
14 14127000
16 16141000
19 18851000
16 16140000
25 25161000
24 24352000
22 22119000
Total Current Liabilities
n/a
136 136084000
149 149342000
145 145400000
157 156822000
364 363986000
176 175554000
171 171336000
Long Term Debt
n/a
152 152127000
159 159208000
167 166784000
175 174890000
0 0
141 141250000
84 83750000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
56 56053000
62 61521000
72 72024000
77 76658000
83 82979000
94 94055000
86 86381000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
24 23637000
28 27851000
31 30693000
36 35599000
42 42348000
49 48684000
49 49467000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
26 25924000
25 25085000
29 29463000
28 27662000
27 27301000
30 29945000
21 21041000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
6 6492000
9 8585000
12 11868000
13 13397000
13 13330000
15 15426000
16 15873000
Total Noncurrent Liabilities
n/a
208 208180000
221 220729000
239 238808000
252 251548000
83 82979000
235 235305000
170 170131000
Total Liabilities
n/a
344 344264000
370 370071000
384 384208000
408 408370000
447 446965000
411 410859000
341 341467000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
366 365781000
395 395389000
429 429031000
469 468953000
513 513256000
572 572182000
637 636991000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-294 -293941000
-409 -408615000
-564 -564091000
-641 -640732000
-753 -752634000
-894 -894285000
-992 -991978000
Retained Earnings
n/a
403 403366000
473 473316000
547 546757000
623 623035000
686 686114000
771 771176000
866 865845000
Other Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Equity Before Minority Interest
n/a
475 475206000
460 460090000
412 411697000
451 451256000
447 446736000
449 449073000
511 510858000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
475 475206000
460 460090000
412 411697000
451 451256000
447 446736000
449 449073000
511 510858000
Total Liabilities & Equity
n/a
819 819470000
830 830161000
796 795905000
860 859626000
894 893701000
860 859932000
852 852325000
Remarks restated on n/a restated on Feb 28, 2011 n/a restated on Feb 27, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 27, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 26, 2016 n/a restated on Jul 29, 2016 n/a
Cash Flow StatementCF data quality: 20% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
67
74
82
86
89
77
99
110
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
28
28
29
29
31
29
31
33
Non-Cash Items
20
34
23
32
21
22
31
23
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
-3
24
-48
27
-9
23
-50
5
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
1
0
0
0
0
0
0
0
Cash from Operating Activities
112
161
86
174
132
151
110
172
Change in Fixed Assets & Intangibles
-26
-21
-26
-30
-35
-29
-44
-44
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-11
-2
-9
-4
-6
-2
0
-7
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
8
1
-1
-1
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-29
-23
-36
-34
-41
-31
-44
-50
Dividends Paid
-6
-8
-12
-13
-13
-14
-14
-16
Cash From (Repayment of) Debt
-19
-15
0
0
0
0
-39
-56
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
1
-104
-136
-48
-76
-86
-44
Increase in Capital Stock
0
1
5
8
12
17
24
15
Decrease in Capital Stock
0
0
-109
-144
-61
-93
-110
-59
Other Financing Activities
9
-3
3
0
6
-9
10
11
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-15
-25
-113
-148
-56
-99
-130
-105
Net Cash Before Disc. Operations and FX
68
113
-62
-8
36
20
-63
16
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
68
113
-62
-8
36
20
-63
16
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
68
113
-62
-8
36
20
-63
16
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 27, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo